Antisense oligonucleotide inhibition of ras
OwnerBrett P. Monia, Lex M. Cowsert +3inventors
InventorsBrett P. Monia, Lex M. Cowsert, Muthiah Manoharan, F. Andrew Dorr, Jon Holmlund
Life of this patent
Estimating the term…
Loading patent…
OwnerBrett P. Monia, Lex M. Cowsert +3inventors
InventorsBrett P. Monia, Lex M. Cowsert, Muthiah Manoharan, F. Andrew Dorr, Jon Holmlund
Estimating the term…
Compositions and are provided which are targeted to nucleic acids methods are provided for the modulation of ras expression. Oligonucleotides encoding human ras. Oligonucleotides specifically hybridizable with mRNA encoding human H-ras, Ki-ras and N-ras are provided. Such oligonucleotides can be used for therapeutics and diagnostics as well as for research purposes. Methods are also disclosed for modulating ras gene expression in cells and tissues using the oligonucleotides provided, and for specific modulation of expression of activated ras. Methods for diagnosis, detection and treatment of conditions, or particular cancers, associated with ras are also disclosed.
A composition comprising an oligonucleotide 8 to 30 nucleotides in length which is targeted to a nucleic acid encoding human ras, and which is capable of inhibiting ras expression, and at least one chemotherapeutic agent.
Dependencies are inferred from the claim text.